What causes anemia with elevated Red Blood Cell (RBC) count, high Red Cell Distribution Width (RDW), and low Mean Corpuscular Volume (MCV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Guidelines

Iron deficiency anemia is the most likely cause of anemia with elevated Red Blood Cell (RBC) count, high Red Cell Distribution Width (RDW), and low Mean Corpuscular Volume (MCV), as it leads to increased RBC production, smaller red blood cells, and variable cell sizes. In this condition, the body produces more red blood cells to compensate for their reduced oxygen-carrying capacity, resulting in elevated RBC counts 1. The MCV (mean corpuscular volume) is low because iron deficiency leads to smaller red blood cells (microcytosis) 2. The RDW (red cell distribution width) is high because there's significant variation in red cell size as the body produces both normal and small cells during the development of iron deficiency.

Some key points to consider in the diagnosis of iron deficiency anemia include:

  • Serum ferritin level < 30 μg/L in the absence of inflammation, or < 100 μg/L in the presence of inflammation, indicates iron deficiency 1
  • Transferrin saturation level < 16% is a sensitive marker of iron deficiency, although it has low specificity 1
  • Elevated CRP or ESR levels can indicate inflammation, which can affect iron metabolism and serum ferritin levels 1
  • Reticulocyte count can help distinguish between iron deficiency anemia and anemia of chronic disease (ACD) 2

Other conditions, such as thalassemia minor, can also present with similar laboratory findings, but require different treatments. Distinguishing between these conditions often requires additional tests like serum ferritin, iron studies, or hemoglobin electrophoresis 2.

In terms of treatment, iron supplementation (typically ferrous sulfate 325mg daily for 3-6 months) is the standard treatment for iron deficiency anemia, while thalassemia is genetic and may not require specific treatment in its minor form. It is essential to determine the underlying cause of anemia to provide effective treatment and improve patient outcomes.

From the Research

Anemia with Elevated RBC Count, High RDW, and Low MCV

  • Anemia with an elevated Red Blood Cell (RBC) count, high Red Cell Distribution Width (RDW), and low Mean Corpuscular Volume (MCV) can be caused by several factors, including:
    • Iron deficiency anemia 3, 4, 5
    • Thalassemia minor 6
    • Polycythemia vera with iron deficiency 6, 7
    • Secondary polycythemia with incidental iron deficiency 6
  • A high RBC count combined with a low MCV is generally attributed to thalassemia minor or polycythemia vera with iron deficiency 6
  • Iron deficiency anemia can be predicted by a high RDW and low MCV, even before anemia develops or during recovery 3, 4, 5
  • A high RDW is a sensitive and specific indicator of iron deficiency anemia, especially in the latent stage 5
  • The combination of a high RBC count and high RDW may indicate polycythemia vera, especially if the MCV is low 7
  • The RBC count and RDW can be used as diagnostic markers for polycythemia vera, in combination with other tests such as the erythrocyte sedimentation rate (ESR) 7

Related Questions

What is the likely cause and appropriate workup and treatment for a patient with an RBC count of 5.46 ×10⁶/µL, low MCH (22.5 pg), low‑normal MCHC (30.6 g/dL), and elevated RDW (15.5 %)?
What does an elevated red blood cell (RBC) count with low mean corpuscular hemoglobin (MCH), low mean corpuscular hemoglobin concentration (MCHC), and high red cell distribution width (RDW) indicate?
What is the most likely diagnosis and recommended evaluation and management for a complete blood count showing elevated red blood cell count, low mean corpuscular volume (MCV), low mean corpuscular hemoglobin (MCH), high red cell distribution width (RDW), neutrophilia, and lymphopenia?
What is the likely cause and recommended work‑up for a patient with increased mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH), low red‑cell distribution width (RDW), and normal hemoglobin (Hgb) and hematocrit (Hct)?
What does it mean to have elevated Hemoglobin (Hb), Mean Corpuscular Volume (MCV), and Mean Corpuscular Hemoglobin (MCH) levels?
Is epistaxis (nosebleed) and hemoptysis (coughing up blood) likely during endotracheal intubation?
Can tapentadol be used with SSRIs (Selective Serotonin Reuptake Inhibitors)?
What is the comparison between Candesartan (Angiotensin II receptor antagonist) and Losartan (Angiotensin II receptor antagonist)?
What is the treatment for intermetatarsal (between the metatarsal bones) bursitis?
What is the comparison between Candesartan (Angiotensin II receptor antagonist), Losartan (Angiotensin II receptor antagonist), and Lisinopril (Angiotensin-converting enzyme inhibitor)?
How do you treat intermetatarsal bursitis with orthotics (Orthotic devices) as a podiatrist (Doctor of Podiatric Medicine)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.